Calcium sulfate

Biocomposites expands its international presence by opening new sales and distribution office in Italy

Retrieved on: 
Tuesday, January 16, 2024
Calcium sulfate, SRL, Sale, Surgeon, Patient, Infection, Hospital

Led by Pierluigi Leone, General Manager, the sales team will continue to work with local agents to fulfil tenders and introduce the broader Biocomposites portfolio to surgeons and hospitals throughout Italy.

Key Points: 
  • Led by Pierluigi Leone, General Manager, the sales team will continue to work with local agents to fulfil tenders and introduce the broader Biocomposites portfolio to surgeons and hospitals throughout Italy.
  • Pierluigi Leone, Amministratore delegato e General Manager of Biocomposites Italy, commented: "This is an exciting time for Biocomposites Italy.
  • We have established an experienced team, incorporated Biocomposites SRL, and set up our new distribution centre in only a few months.
  • We formally opened the office at the beginning of the year and are already providing surgeons with our unique products.

Biocomposites expands its international presence by opening new sales and distribution office in Italy

Retrieved on: 
Tuesday, January 16, 2024
Calcium sulfate, SRL, Sale, Surgeon, Patient, Infection, Hospital

Led by Pierluigi Leone, General Manager, the sales team will continue to work with local agents to fulfil tenders and introduce the broader Biocomposites portfolio to surgeons and hospitals throughout Italy.

Key Points: 
  • Led by Pierluigi Leone, General Manager, the sales team will continue to work with local agents to fulfil tenders and introduce the broader Biocomposites portfolio to surgeons and hospitals throughout Italy.
  • Pierluigi Leone, Amministratore delegato e General Manager of Biocomposites Italy, commented: "This is an exciting time for Biocomposites Italy.
  • We have established an experienced team, incorporated Biocomposites SRL, and set up our new distribution centre in only a few months.
  • We formally opened the office at the beginning of the year and are already providing surgeons with our unique products.

First Phosphate Corp. Receives Successful Results for the Pilot Production of Merchant Grade Phosphoric Acid (MGA) from Its Phosphate Concentrate

Retrieved on: 
Wednesday, September 6, 2023
Phosphate, Housing, Construction, CSE, MER, FSE, Calcium sulfate, Calcium, SGS, CPP, Iron, Corrosion, National instrument, Chlorine, Water, OTC, MGA, PPA, Environment, News, H2SO4, Phosphorus, Fine chemical, Financial adviser, Fertilizer, Typesetting, P2O5

Prayon has begun assessing product quality and process feasibility through pilot testing of the First Phosphate rock concentrate to determine the optimal process parameters for MGA production.

Key Points: 
  • Prayon has begun assessing product quality and process feasibility through pilot testing of the First Phosphate rock concentrate to determine the optimal process parameters for MGA production.
  • The main results of the MGA tests are summarized below:
    The phosphate rock concentrate can be considered a high-grade igneous rock with about 40.6% P2O5 content.
  • The general impurity content is low, especially chlorine (~630 ppm) compared to other rock concentrates mined from the same region.
  • The operation of the pilot plant using this phosphate rock was stable and quite easily operable in the CPP process route.

Sodium sulfate market size to grow by 1,427.55 thousand units between 2021 and 2026; Growth driven by increasing demand for sodium sulfate in China - Technavio

Retrieved on: 
Tuesday, April 4, 2023
Adsorption, Food industry, Agriculture, Textile industry, MEA, Calcium sulfate, Sulfur, Zinc sulfate, Paper, Geography, Pulp (paper), Potash, Pet industry, Growth

Sodium sulfate also acts as an electrolyte for migration, adsorption, and fixation of the dyestuff to the cellulose material.

Key Points: 
  • Sodium sulfate also acts as an electrolyte for migration, adsorption, and fixation of the dyestuff to the cellulose material.
  • Such properties have increased the use of sodium sulfate as the dyeing agent in the textile industry.
  • This is reducing the demand and consumption of sodium sulfate, which is hindering the growth of the market.
  • Growth of the sodium sulfate market industry across APAC, Europe, North America, MEA, and South America
    Gain instant access to 17,000+ market research reports.

Biocomposites to present latest STIMULAN® data at the European Bone and Joint Infection Society Annual Meeting

Retrieved on: 
Thursday, September 1, 2022
Genex Power, Technology, Biofilm, Research, Immunity, Spine, Transanal irrigation, Doctor of Philosophy, Genetically modified bacteria, Human musculoskeletal system, Vancomycin, Infection, Calcium sulfate, Diagnosis, Tobramycin, Ohio State University, Rohr, Hospital, Surgeon, Company, Ankle, Podiatry, 2021 Essex County Council election, Trauma, Knowledge, Foot, Patient, Vaccine, Antibiotics, Dentistry, Pharmaceutical industry, Orthopedic surgery

The two in-vitro studies demonstrate the efficacy of STIMULAN beads in combating bacterial biofilms when combined with antibiotics.

Key Points: 
  • The two in-vitro studies demonstrate the efficacy of STIMULAN beads in combating bacterial biofilms when combined with antibiotics.
  • Michael Harris, Chief Executive Officer of Biocomposites, added: "Biocomposites is pleased to be leading the field in orthopaedics by once again presenting new STIMULAN data at this important annual meeting.
  • EBJIS holds an annual meeting which brings together experts, practitioners and companies involved in the treatment of bone and joint infections.
  • This year, the theme of the meeting will be 'optimising diagnosis and management of bone and joint infections'.

Biocomposites to present latest STIMULAN® data at the European Bone and Joint Infection Society Annual Meeting

Retrieved on: 
Thursday, September 1, 2022
Genex Power, Technology, Biofilm, Research, Immunity, Spine, Transanal irrigation, Doctor of Philosophy, Genetically modified bacteria, Human musculoskeletal system, Vancomycin, Infection, Calcium sulfate, Diagnosis, Tobramycin, Ohio State University, Rohr, Hospital, Surgeon, Company, Ankle, Podiatry, 2021 Essex County Council election, Trauma, Knowledge, Foot, Patient, Vaccine, Antibiotics, Dentistry, Pharmaceutical industry, Orthopedic surgery

The two in-vitro studies demonstrate the efficacy of STIMULAN beads in combating bacterial biofilms when combined with antibiotics.

Key Points: 
  • The two in-vitro studies demonstrate the efficacy of STIMULAN beads in combating bacterial biofilms when combined with antibiotics.
  • Michael Harris, Chief Executive Officer of Biocomposites, added: "Biocomposites is pleased to be leading the field in orthopaedics by once again presenting new STIMULAN data at this important annual meeting.
  • EBJIS holds an annual meeting which brings together experts, practitioners and companies involved in the treatment of bone and joint infections.
  • This year, the theme of the meeting will be 'optimising diagnosis and management of bone and joint infections'.

Genesys-PWT Completes First Production Run of Powdered Cleaners and Supplies GenMine Product Line to Mining Clients

Retrieved on: 
Wednesday, June 15, 2022
Industry, Water, Calumet Specialty Products Partners, Safety, TSX, Environment, Innovation, PH, SEDAR, Social, Risk, Forward-looking statement, Calcium sulfate, Engineering, Biophysical environment, O&M, CO2, Corporation, Health, WTS, HEO, Mining, Legislation, ESG, GLOBE, SP

Additionally, Genesys-PWT has secured new business in the last few months with various mining sites in North America.

Key Points: 
  • Additionally, Genesys-PWT has secured new business in the last few months with various mining sites in North America.
  • Because of their compact size, these powdered cleaners have a lower water footprint, reduce freight costs, and cause less CO2 emissions compared to equivalent products in liquid form.
  • Furthermore, Genesys-PWT has recently provided its GenMine product line to several mining sites in Canada and the United States.
  • This product line, specifically developed for the mining sector, is formulated for complex waters featuring extreme levels of pH, gypsum, and heavy metals.

Biocomposites wins two Queen's Awards for Enterprise in Innovation and International Trade

Retrieved on: 
Thursday, April 21, 2022
Podiatry, Queen, Foot, Research, Tobramycin, Calcium sulfate, Trauma, Patient, Spine, Infection, Queen's Award, Growth, Surgeon, Enterprise, International trade, Innovation, Ankle, Genetically modified bacteria, Queen's Awards for Enterprise, Vancomycin, Pharmaceutical industry, Entertainment, Antibiotics, Biocomposite, EU

KEELE, England, April 21, 2022 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is delighted to have been honoured with two Queen's Awards for Enterprise for Innovation and International Trade.

Key Points: 
  • Biocomposites is one of only seven organisations nationally to achieve two Queen's Awards in 2022.
  • The Queen's Awards for Enterprise is one of the world's most distinguished business awards, celebrating and recognising enterprise excellence in UK companies.
  • Biocomposites has also been recognised in the International Trade category for outstanding continuous growth in overseas sales.
  • Michael Harris, Chief Executive Officer of Biocomposites, said:"The Queen's Awards are the most prestigious business awards in the UK and we are proud that Biocomposites has been honoured with two of them.

Biocomposites wins two Queen's Awards for Enterprise in Innovation and International Trade

Retrieved on: 
Thursday, April 21, 2022
Podiatry, Queen, Foot, Research, Tobramycin, Calcium sulfate, Trauma, Patient, Spine, Infection, Queen's Award, Growth, Surgeon, Enterprise, International trade, Innovation, Ankle, Genetically modified bacteria, Queen's Awards for Enterprise, Vancomycin, Pharmaceutical industry, Entertainment, Antibiotics, Biocomposite, EU

KEELE, England, April 21, 2022 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, is delighted to have been honoured with two Queen's Awards for Enterprise for Innovation and International Trade.

Key Points: 
  • Biocomposites is one of only seven organisations nationally to achieve two Queen's Awards in 2022.
  • The Queen's Awards for Enterprise is one of the world's most distinguished business awards, celebrating and recognising enterprise excellence in UK companies.
  • Biocomposites has also been recognised in the International Trade category for outstanding continuous growth in overseas sales.
  • Michael Harris, Chief Executive Officer of Biocomposites, said:"The Queen's Awards are the most prestigious business awards in the UK and we are proud that Biocomposites has been honoured with two of them.

Biocomposites signs agreement with Zimmer Biomet to distribute new genex Bone Graft Substitute

Retrieved on: 
Tuesday, March 22, 2022
CMFT, Calcium sulfate, Podiatry, Society, NYSE, Trauma, Zimmer Biomet, Ankle, Foot, Pain, Quality of life, Genex Power, Surgeon, Sheep, Physician, Spine, 50/50 (2011 film), Patient, Infection, Pharmaceutical industry, Phosphorus, Dentistry

genex Bone Graft Substitute is a biphasic composite of exceptional purity that is specifically formulated tobalance osteoconductive scaffold strength and persistence in the body to enable the optimal remodelling of bone architecture1.

Key Points: 
  • genex Bone Graft Substitute is a biphasic composite of exceptional purity that is specifically formulated tobalance osteoconductive scaffold strength and persistence in the body to enable the optimal remodelling of bone architecture1.
  • genex Bone Graft Substitute's 50:50 biphasic composition of calcium sulfate and -tricalcium phosphate is not the only performance factor.
  • Michael Harris, Chief Executive Officer of Biocomposites, commented: "I am delighted we are partnering with Zimmer Biomet to deliver our new genex Bone Graft Substitute product to the U.S. market.
  • Bone healing response to a synthetic calcium sulfate/-tricalcium phosphate graft material in a sheep vertebral body defect model.